PodParley PodParley
PodParley
FDA approves BMS schizophrenia drug, bluebird bio announces layoffs, J&J talc subsidiary files for bankruptcy [The good, the bad, the ugly] episode artwork

EPISODE · Sep 30, 2024 · 3 MIN

FDA approves BMS schizophrenia drug, bluebird bio announces layoffs, J&J talc subsidiary files for bankruptcy [The good, the bad, the ugly]

from Off Script: A Pharma Manufacturing Podcast · host Pharma Manufacturing

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:   The good —FDA approves BMS schizophrenia drug  The bad — bluebird bio announces layoffs  The ugly —J&J talc subsidiary files for bankruptcy

Episode metadata supplied by the publisher feed · Published Sep 30, 2024

Embed this episode

Ready to play

FDA approves BMS schizophrenia drug, bluebird bio announces layoffs, J&J talc subsidiary files for bankruptcy [The good, the bad, the ugly]

0:00 3:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off Script: A Pharma Manufacturing Podcast?

This episode is 3 minutes long.

When was this Off Script: A Pharma Manufacturing Podcast episode published?

This episode was published on September 30, 2024.

Can I download this Off Script: A Pharma Manufacturing Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!